RODRIGO FARRALES: Open Payments
NPI 1235379678 · RIVER FOREST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 30 payments from 8 companies in 2025. Trend: 2023 $1,081 · 2024 $1,017 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $339 |
| Alkermes, Inc. | 6 | $335 |
| E.R. Squibb & Sons, L.L.C. | 8 | $297 |
| Neurocrine BioSciences, Inc. | 2 | $190 |
| Janssen Pharmaceuticals, Inc | 1 | $120 |
| ABBVIE INC. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
Products named: COBENFY, LYBALVI, REXULTI, ABILIFY ASIMTUFII, SPRAVATO, ARISTADA, VRAYLAR, CAPLYTA.
Industry payments across IL — which companies pay providers there.
